
PARSIPPANY, NJ, Oct. 17, 2011 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today confirmed that its subsidiary, Watson Laboratories, Inc. - Florida, filed an Abbreviated New Drug Application (ANDA) with the US Food and Drug Administration ... PRESS RELEASE: Watson Confirms Atelvia(TM) Patent Challenge
No comments:
Post a Comment